RadNet (RDNT) to Release Earnings on Monday

RadNet (NASDAQ:RDNT) is scheduled to issue its quarterly earnings data before the market opens on Monday, November 11th. Analysts expect the company to announce earnings of $0.15 per share for the quarter. Investors that wish to listen to the company’s conference call can do so using this link.

RadNet (NASDAQ:RDNT) last announced its quarterly earnings data on Wednesday, August 7th. The medical research company reported $0.16 earnings per share for the quarter, missing the consensus estimate of $0.17 by ($0.01). The business had revenue of $459.70 million for the quarter, compared to the consensus estimate of $438.53 million. RadNet had a return on equity of 4.30% and a net margin of 0.58%. RadNet’s quarterly revenue was up 13.9% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.24 earnings per share. On average, analysts expect RadNet to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

RadNet Stock Performance

NASDAQ:RDNT opened at $72.53 on Friday. The company has a quick ratio of 2.12, a current ratio of 2.12 and a debt-to-equity ratio of 0.92. The firm has a market capitalization of $5.36 billion, a PE ratio of 518.07 and a beta of 1.75. RadNet has a twelve month low of $28.27 and a twelve month high of $72.69. The stock’s 50-day simple moving average is $67.36 and its 200 day simple moving average is $61.90.

Insiders Place Their Bets

In other RadNet news, EVP Michael N. Murdock sold 15,000 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $62.78, for a total value of $941,700.00. Following the completion of the transaction, the executive vice president now owns 48,144 shares in the company, valued at $3,022,480.32. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 5.12% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several brokerages recently weighed in on RDNT. Sidoti raised shares of RadNet to a “strong-buy” rating in a research note on Friday, October 4th. Truist Financial upped their price target on RadNet from $70.00 to $80.00 and gave the company a “buy” rating in a research report on Monday, September 23rd. Jefferies Financial Group raised their price objective on RadNet from $75.00 to $80.00 and gave the stock a “buy” rating in a research report on Thursday, September 19th. Finally, Barclays upgraded RadNet from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $57.00 to $79.00 in a report on Friday, September 6th. One analyst has rated the stock with a sell rating, four have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, RadNet currently has an average rating of “Moderate Buy” and a consensus target price of $74.75.

About RadNet

RadNet, Inc, together with its subsidiaries, provides outpatient diagnostic imaging services in the United States. The company operates in two segments: Imaging Centers and Artificial Intelligence. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services.